Last update Nov. 9, 2024
Compatible
We do not have alternatives for Disopyramide since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Disopyramide in other languages or writings:
Main tradenames from several countries containing Disopyramide in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Disopyramide is a class Ia antiarrhythmic with an action on the heart similar to that of quinidine. It also has antimuscarinic properties. It is used in the treatment of supraventricular and ventricular arrhythmias. Oral or intravenous administration.
It is excreted in breast milk in a clinically insignificant amount (Wakaumi 2005, Ellsworth 1989, Hoppu 1986, MacKintosh 1985, Barnett 1982) and no problems have been observed in infants born to mothers treated with this drug. (Ellsworth 1989, Hoppu 1986, MacKintosh 1985, Barnett 1982 )
Plasma levels in these infants were very low or below the limit of detection. (Hoppu 1986, MacKintosh 1985, Barnett 1982)
Because of its antimuscarinic action, it may interfere with milk production in the first 4 to 6 weeks after delivery.
American Academy of Pediatrics: medication generally compatible with breast-feeding. (AAP 2001)
....